Class-action lawsuit in Canada about Zofran morning sickness drug use in pregnancy

Woman, whose daughter died at 14 months, sues GSK over drug she took while pregnant

Zofran image
Woman, whose daughter died at 14 months, sues GSK and Novartis over Zofran drug she took while pregnant.

Nov 27, 2015 – CALGARY – The makers of an anti-nausea drug prescribed to pregnant women for morning sickness are being sued for $11-million by an Alberta woman whose daughter died 10 years ago.

In 2012, the US Department of Justice announced that GlaxoSmithKline, maker of Zofran, would pay more than $1 billion to settle claims that it illegally marketed Zofran and other medications for off-label, unapproved uses. Specifically, GlaxoSmithKline allegedly “promoted certain forms of Zofran, approved only for post-operative nausea, for the treatment of morning sickness in pregnant women.” Although doctors are free to prescribe Zofran for off-label use, it is illegal for a drug company to market its medications for unapproved uses.

Sources and more information

  • Woman, whose daughter died at 14 months, sues GSK over drug she took while pregnant, cnews, Nov 27, 2015.
  • Zofran Birth Defects, lawyersandsettlements, Feb-3-15.